应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMNN Imunon, Inc.
已收盘 11-22 16:00:00 EST
0.8120
+0.1190
+17.17%
盘后
0.8001
-0.0119
-1.47%
19:20 EST
最高
0.8300
最低
0.6900
成交量
29.68万
今开
0.6900
昨收
0.6930
日振幅
20.20%
总市值
1,177万
流通市值
1,120万
总股本
1,450万
成交额
23.19万
换手率
2.15%
流通股本
1,379万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Imunon, Inc.盘中异动 股价大跌5.41%
市场透视 · 11-21 00:40
Imunon, Inc.盘中异动 股价大跌5.41%
Imunon, Inc.盘中异动 急速跳水5.18%
市场透视 · 11-18
Imunon, Inc.盘中异动 急速跳水5.18%
Imunon, Inc.2024财年第三财季实现净利润-4.85百万美元,同比减少39.37%
市场透视 · 11-17
Imunon, Inc.2024财年第三财季实现净利润-4.85百万美元,同比减少39.37%
Imunon, Inc.盘中异动 急速下跌5.40%
市场透视 · 11-15
Imunon, Inc.盘中异动 急速下跌5.40%
Imunon, Inc.盘中异动 早盘股价大涨5.11%报0.815美元
市场透视 · 11-13
Imunon, Inc.盘中异动 早盘股价大涨5.11%报0.815美元
Imunon, Inc.盘中异动 股价大涨13.11%报1.060美元
市场透视 · 11-07
Imunon, Inc.盘中异动 股价大涨13.11%报1.060美元
Imunon Inc 预计每股亏损40美分 - 财报前瞻
Reuters · 11-06
Imunon Inc 预计每股亏损40美分 - 财报前瞻
Imunon, Inc.盘中异动 股价大跌6.07%
市场透视 · 09-20
Imunon, Inc.盘中异动 股价大跌6.07%
Imunon, Inc.盘中异动 早盘快速跳水5.79%报1.14美元
自选股智能写手 · 08-20
Imunon, Inc.盘中异动 早盘快速跳水5.79%报1.14美元
Imunon, Inc.2024财年第二财季实现净利润-4.79百万美元,同比增加13.85%
自选股智能写手 · 08-20
Imunon, Inc.2024财年第二财季实现净利润-4.79百万美元,同比增加13.85%
Imunon, Inc.盘中异动 股价大跌5.13%
自选股智能写手 · 08-14
Imunon, Inc.盘中异动 股价大跌5.13%
Imunon Inc 预计每股亏损54美分 - 财报前瞻
Reuters · 08-12
Imunon Inc 预计每股亏损54美分 - 财报前瞻
Imunon, Inc.盘中异动 大幅上涨5.55%报1.13美元
自选股智能写手 · 08-09
Imunon, Inc.盘中异动 大幅上涨5.55%报1.13美元
Imunon Inc 预计每股亏损54美分 - 财报前瞻
Reuters · 08-07
Imunon Inc 预计每股亏损54美分 - 财报前瞻
HC Wainwright & Co.:维持Imunon(IMNN.US)评级,由买入调整至买入评级, 目标价由12.
智通财经 · 08-05
HC Wainwright & Co.:维持Imunon(IMNN.US)评级,由买入调整至买入评级, 目标价由12.
Imunon, Inc.股价重挫11.94% 市值跌202.9万美元
自选股智能写手 · 08-02
Imunon, Inc.股价重挫11.94% 市值跌202.9万美元
Dermata Therapeutics, Inc.盘中异动 早盘急速跳水8.47%
自选股智能写手 · 07-31
Dermata Therapeutics, Inc.盘中异动 早盘急速跳水8.47%
Imunon, Inc.股价重挫46.80% 市值跌777.02万美元
自选股智能写手 · 07-31
Imunon, Inc.股价重挫46.80% 市值跌777.02万美元
Imunon(IMNN)涨超164% 使用Imnn-001治疗的晚期卵巢癌患者综合生存期增长11.1个月
金吾财讯 · 07-30
Imunon(IMNN)涨超164% 使用Imnn-001治疗的晚期卵巢癌患者综合生存期增长11.1个月
Imunon, Inc.股价飙升163.87% 市值涨4837.28万美元
自选股智能写手 · 07-30
Imunon, Inc.股价飙升163.87% 市值涨4837.28万美元
暂无数据
公司概况
公司名称:
Imunon, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Imunon, Inc.成立于1982年,是一家特拉华州公司。Celsion公司是一家完全集成的肿瘤药物开发公司,致力于开发创新癌症治疗,包括化学疗法执导,免疫治疗和RNA-或DNA为基础的治疗组合。该公司的首席程序是ThermoDox,多柔比星的专利热活化脂质体封装,目前处于III期临床试验为原发性肝癌的治疗(OPTIMA研究)和II期临床试验复发治疗胸壁乳腺癌(DIGNITY研究)。其管道还包括GEN-1(原名EGEN-001),基于DNA的免疫治疗的卵巢癌和脑癌的局部治疗。该公司有三个平台技术为治疗的发展对于那些难以治疗的癌症,新型核酸为基础的免疫疗法等抗癌DNA或RNA疗法,包括TheraPlas和TheraSilence。从2014年上半年开始,正在对产品ThermoDox进行针对原发性肝癌的III期临床试验(OPTIMA研究)和针对复发性胸壁乳腺癌的II期临床试验(DIGNITY研究)。
发行价格:
--
{"stockData":{"symbol":"IMNN","market":"US","secType":"STK","nameCN":"Imunon, Inc.","latestPrice":0.812,"timestamp":1732309200000,"preClose":0.693,"halted":0,"volume":296790,"hourTrading":{"tag":"盘后","latestPrice":0.8001,"preClose":0.812,"latestTime":"19:20 EST","volume":8385,"amount":6769.9595,"timestamp":1732321248233},"delay":0,"floatShares":13791337,"shares":14500685,"eps":-1.901706,"marketStatus":"已收盘","marketStatusCode":5,"change":0.119,"latestTime":"11-22 16:00:00 EST","open":0.69,"high":0.83,"low":0.69,"amount":231947.64726899998,"amplitude":0.20202,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.901706,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":959745600000,"adjPreClose":0.693,"preHourTrading":{"tag":"盘前","latestPrice":0.6931,"preClose":0.693,"latestTime":"08:00 EST","volume":39,"amount":27.030900000000003,"timestamp":1732280400391},"postHourTrading":{"tag":"盘后","latestPrice":0.8001,"preClose":0.812,"latestTime":"19:20 EST","volume":8385,"amount":6769.9595,"timestamp":1732321248233},"volumeRatio":1.756256},"requestUrl":"/m/hq/s/IMNN/tweets","defaultTab":"tweets","newsList":[{"id":"2485144038","title":"Imunon, Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485144038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485144038?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:40","pubTimestamp":1732120855,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时40分,Imunon, Inc.股票出现异动,股价大幅下跌5.41%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。其相关个股中,Forte Biosciences, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃,换手率分别为1391.80%、1198.95%、499.29%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.,振幅分别为185.64%、169.09%、135.22%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004055971a7bb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121004055971a7bb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2484672105","title":"Imunon, Inc.盘中异动 急速跳水5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672105?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:45","pubTimestamp":1731944737,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时45分,Imunon, Inc.股票出现波动,股价快速跳水5.18%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大,Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃,换手率分别为687.86%、559.45%、435.27%,振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为217.24%、75.18%、73.24%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823453798e434ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823453798e434ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2484510172","title":"Imunon, Inc.2024财年第三财季实现净利润-4.85百万美元,同比减少39.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484510172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484510172?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:01","pubTimestamp":1731772868,"startTime":"0","endTime":"0","summary":"11月17日,Imunon, Inc.公布财报,公告显示公司2024财年第三财季净利润为-4.85百万美元,同比减少39.37%;其中营业收入为0.00美元,每股基本收益为-0.34美元。从资产负债表来看,Imunon, Inc.总负债6.20百万美元,其中短期债务508450.00美元,资产负债比为2.33,流动比率为2.31。机构评级:截至2024年11月17日,当前有5家机构对Imunon, Inc.目标价做出预测,其中目标均价为13.20美元,其中最低目标价为5.00美元,最高目标价为29.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000146a23e0564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000146a23e0564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN"],"gpt_icon":0},{"id":"2483633808","title":"Imunon, Inc.盘中异动 急速下跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483633808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483633808?lang=zh_cn&edition=full","pubTime":"2024-11-15 02:41","pubTimestamp":1731609681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日02时41分,Imunon, Inc.股票出现波动,股价快速下跌5.40%。Imunon, Inc.股票所在的生物技术行业中,整体跌幅为0.96%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为4338.59%、3302.58%、382.76%,振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为249.67%、211.36%、188.46%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115024121a2385685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115024121a2385685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2483814448","title":"Imunon, Inc.盘中异动 早盘股价大涨5.11%报0.815美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483814448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483814448?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:38","pubTimestamp":1731508710,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时38分,Imunon, Inc.股票出现波动,股价急速上涨5.11%。截至发稿,该股报0.815美元/股,成交量9860股,换手率0.07%,振幅0.15%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223830971a64a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223830971a64a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2481845631","title":"Imunon, Inc.盘中异动 股价大涨13.11%报1.060美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481845631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481845631?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:00","pubTimestamp":1730991609,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时00分,Imunon, Inc.股票出现波动,股价快速拉升13.11%。截至发稿,该股报1.060美元/股,成交量1.7351万股,换手率0.12%,振幅3.70%。Imunon, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107230009abaa83cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107230009abaa83cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2481176600","title":"Imunon Inc 预计每股亏损40美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481176600","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481176600?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:25","pubTimestamp":1730903141,"startTime":"0","endTime":"0","summary":" * Imunon Inc 预计在11月7日公布截至0001年1月1日的业绩报告时,季度收入将没有变化。* * LSEG分析师对Imunon Inc的平均预期是每股亏损40美分。* 华尔街对 Imunon Inc 的 12 个月目标价中位数为 12.00 美元,高于上一交易日 0.98 美元的收盘价。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Imunon Inc 预计每股亏损40美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNN"],"gpt_icon":0},{"id":"2468036625","title":"Imunon, Inc.盘中异动 股价大跌6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468036625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468036625?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:39","pubTimestamp":1726839582,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时39分,Imunon, Inc.股票出现波动,股价大幅下跌6.07%。Imunon, Inc.股票所在的生物技术行业中,整体跌幅为0.90%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Novabay Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Novabay Pharmaceuticals, Inc.、Galmed Pharmaceuticals Ltd.、Corbus Pharmaceuticals Holdings, Inc.较为活跃,换手率分别为1019.06%、387.94%、18.06%,振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Galmed Pharmaceuticals Ltd.、Zevra Therapeutics, Inc.,振幅分别为50.21%、16.19%、16.08%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920213943ab64e3ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920213943ab64e3ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2460888891","title":"Imunon, Inc.盘中异动 早盘快速跳水5.79%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460888891","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460888891?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:33","pubTimestamp":1724164415,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时33分,Imunon, Inc.股票出现异动,股价急速下跌5.79%。截至发稿,该股报1.14美元/股,成交量37.431万股,换手率2.60%,振幅8.26%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820223335ab5ea523&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820223335ab5ea523&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2460059827","title":"Imunon, Inc.2024财年第二财季实现净利润-4.79百万美元,同比增加13.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460059827","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460059827?lang=zh_cn&edition=full","pubTime":"2024-08-20 00:00","pubTimestamp":1724083224,"startTime":"0","endTime":"0","summary":"8月20日,Imunon, Inc.公布财报,公告显示公司2024财年第二财季净利润为-4.79百万美元,同比增加13.85%;其中营业收入为0.00美元,每股基本收益为-0.51美元。从资产负债表来看,Imunon, Inc.总负债5.95百万美元,其中短期债务516223.00美元,资产负债比为1.63,流动比率为1.51。机构评级:截至2024年8月20日,当前有4家机构对Imunon, Inc.目标价做出预测,其中目标均价为9.75美元,其中最低目标价为5.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408200000329f3a7e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408200000329f3a7e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN"],"gpt_icon":0},{"id":"2459103583","title":"Imunon, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459103583","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459103583?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:36","pubTimestamp":1723646167,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时36分,Imunon, Inc.股票出现波动,股价急速跳水5.13%。截至发稿,该股报1.02美元/股,成交量23.3187万股,换手率1.62%,振幅7.39%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814223607a1d44918&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814223607a1d44918&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2458981757","title":"Imunon Inc 预计每股亏损54美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458981757","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458981757?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:31","pubTimestamp":1723473119,"startTime":"0","endTime":"0","summary":" * Imunon公司 将于8月14日公布截至2024年6月30日的财报,预计该公司的季度收入将保持不变。* * LSEG的分析师平均预计Imunon Inc每股亏损54美分。* 华尔街对 Imunon Inc 的 12 个月目标价中位数为 11.00 美元,高于其最新收盘价 1.09 美元。8月12日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Imunon Inc 预计每股亏损54美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNN"],"gpt_icon":0},{"id":"2458340737","title":"Imunon, Inc.盘中异动 大幅上涨5.55%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458340737","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458340737?lang=zh_cn&edition=full","pubTime":"2024-08-09 02:03","pubTimestamp":1723140220,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日02时03分,Imunon, Inc.股票出现波动,股价快速拉升5.55%。截至发稿,该股报1.13美元/股,成交量30.1527万股,换手率2.09%,振幅8.41%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为3.24%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809020341af96a38b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809020341af96a38b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2457778300","title":"Imunon Inc 预计每股亏损54美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457778300","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457778300?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:32","pubTimestamp":1722969138,"startTime":"0","endTime":"0","summary":" * Imunon Inc 预计在8月8日公布截至2024年6月30日的业绩时,季度收入将没有变化(预计)。* * LSEG 的分析师平均预计 Imunon Inc 每股亏损 54 美分。* 华尔街对 Imunon Inc 的 12 个月目标价中位数为 11.00 美元,高于其最新收盘价 1.22 美元。8月6日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Imunon Inc 预计每股亏损54美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNN"],"gpt_icon":0},{"id":"2457474091","title":"HC Wainwright & Co.:维持Imunon(IMNN.US)评级,由买入调整至买入评级, 目标价由12.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457474091","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457474091?lang=zh_cn&edition=full","pubTime":"2024-08-05 18:46","pubTimestamp":1722854816,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2456891242","title":"Imunon, Inc.股价重挫11.94% 市值跌202.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456891242","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456891242?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:30","pubTimestamp":1722605425,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时30分,Imunon, Inc.股票出现异动,股价大幅下跌11.94%。截至发稿,该股报1.18美元/股,成交量36.7448万股,换手率2.55%,振幅1.49%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.92%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022130269682338a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022130269682338a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":1},{"id":"2455555132","title":"Dermata Therapeutics, Inc.盘中异动 早盘急速跳水8.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455555132","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455555132?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:54","pubTimestamp":1722434084,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时54分,Dermata Therapeutics, Inc.股票出现异动,股价急速下跌8.47%。Dermata Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.80%。Dermata Therapeutics, Inc.公司简介:Dermata Therapeutics Inc 是一家临床阶段的医学皮肤病学公司,专注于识别、开发和商业化用于治疗医学和美容皮肤状况的疾病候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731215444af95242e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731215444af95242e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DRMA","BK4539","BK4139","LENZ","BK4007","IMNN","DRMAW"],"gpt_icon":1},{"id":"2455513151","title":"Imunon, Inc.股价重挫46.80% 市值跌777.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455513151","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455513151?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:32","pubTimestamp":1722432733,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时32分,Imunon, Inc.股票出现异动,股价快速下挫46.80%。截至发稿,该股报1.77美元/股,成交量449.765万股,换手率47.84%,振幅1.81%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.73%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312132139f022e0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312132139f022e0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":1},{"id":"2455956329","title":"Imunon(IMNN)涨超164% 使用Imnn-001治疗的晚期卵巢癌患者综合生存期增长11.1个月","url":"https://stock-news.laohu8.com/highlight/detail?id=2455956329","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455956329?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:32","pubTimestamp":1722349929,"startTime":"0","endTime":"0","summary":"金吾财讯 | Imunon(IMNN)涨超164%,截止发稿,报3.18美元。消息面上,Imunon宣布IMNN-001所进行二阶段研究结果,该项目研究治疗卵巢癌。结果显示,使用Imnn-001治疗的晚期卵巢癌患者综合生存期增长了11.1个月。据悉,治疗方法IMNN-001是一种基于DNA的免疫疗法。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"278373","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2455376249","title":"Imunon, Inc.股价飙升163.87% 市值涨4837.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455376249","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455376249?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:31","pubTimestamp":1722346282,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时31分,Imunon, Inc.股票出现波动,股价急速拉升163.87%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。其相关个股中,Imunon, Inc.、Processa Pharmaceuticals, Inc.、Pharming Group Nv涨幅较大,Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.、Imunon, Inc.较为活跃,换手率分别为739.35%、704.56%、568.86%,振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.,振幅分别为46.22%、27.06%、8.64%。Imunon, Inc.公司简介:Imunon Inc正在开发新的药物,利用生命的组成部分与人体的免疫系统协调工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213122956d3c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213122956d3c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.imunon.com","stockEarnings":[{"period":"1week","weight":-0.0735},{"period":"1month","weight":-0.2857},{"period":"3month","weight":-0.45},{"period":"6month","weight":-0.5411},{"period":"1year","weight":-0.2214},{"period":"ytd","weight":0.0191}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Imunon, Inc.成立于1982年,是一家特拉华州公司。Celsion公司是一家完全集成的肿瘤药物开发公司,致力于开发创新癌症治疗,包括化学疗法执导,免疫治疗和RNA-或DNA为基础的治疗组合。该公司的首席程序是ThermoDox,多柔比星的专利热活化脂质体封装,目前处于III期临床试验为原发性肝癌的治疗(OPTIMA研究)和II期临床试验复发治疗胸壁乳腺癌(DIGNITY研究)。其管道还包括GEN-1(原名EGEN-001),基于DNA的免疫治疗的卵巢癌和脑癌的局部治疗。该公司有三个平台技术为治疗的发展对于那些难以治疗的癌症,新型核酸为基础的免疫疗法等抗癌DNA或RNA疗法,包括TheraPlas和TheraSilence。从2014年上半年开始,正在对产品ThermoDox进行针对原发性肝癌的III期临床试验(OPTIMA研究)和针对复发性胸壁乳腺癌的II期临床试验(DIGNITY研究)。","yearOnYearQuotes":[{"month":1,"riseRate":0.4375,"avgChangeRate":0.093744},{"month":2,"riseRate":0.354839,"avgChangeRate":0.032471},{"month":3,"riseRate":0.5,"avgChangeRate":0.046758},{"month":4,"riseRate":0.34375,"avgChangeRate":-0.043702},{"month":5,"riseRate":0.333333,"avgChangeRate":0.069253},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.032462},{"month":7,"riseRate":0.393939,"avgChangeRate":-0.047127},{"month":8,"riseRate":0.424242,"avgChangeRate":0.013026},{"month":9,"riseRate":0.30303,"avgChangeRate":-0.076521},{"month":10,"riseRate":0.30303,"avgChangeRate":-0.041509},{"month":11,"riseRate":0.30303,"avgChangeRate":-0.026791},{"month":12,"riseRate":0.4375,"avgChangeRate":-0.045613}],"exchange":"NASDAQ","name":"Imunon, Inc.","nameEN":"Imunon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Imunon, Inc.(IMNN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Imunon, Inc.(IMNN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Imunon, Inc.,IMNN,Imunon, Inc.股票,Imunon, Inc.股票老虎,Imunon, Inc.股票老虎国际,Imunon, Inc.行情,Imunon, Inc.股票行情,Imunon, Inc.股价,Imunon, Inc.股市,Imunon, Inc.股票价格,Imunon, Inc.股票交易,Imunon, Inc.股票购买,Imunon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Imunon, Inc.(IMNN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Imunon, Inc.(IMNN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}